Cytology and Genetics

, Volume 41, Issue 5, pp 298–302 | Cite as

Frequency of Pro12Ala-polymorphism of the gene PPARγ2 in the Ukrainian population and its possible relation to the development of the metabolic syndrome

  • I. P. Kaydashev
  • A. M. Rasin
  • O. A. Shlykova
  • I. M. Gorbas’
  • I. P. Smirnova
  • A. V. Petrushov
  • M. S. Rasin
Article

Abstract

The distribution of Pro12Ala polymorphism is studied for the first time in the Ukrainian population, using 39 healthy individuals and 42 male subjects aged 40–65 with symptoms of the metabolic syndrome. The frequency of the allele 12Ala is found to be 27.4%, that of the Pro12Ala genotype, 32.6%, and that of the Ala12Ala genotype, 4.4%. These figures are close to the results found for the Czech population. Among individuals with the metabolic syndrome the frequency of the allele 12Ala is reliably less, or 18.4%, which corresponds to previously established data on individuals with Type 2 diabetes mellitus. A trend towards increasing body mass index among individuals with the 12Ala allele is found in the group of patients with symptoms of the metabolic syndrome.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Reaven, G.M., Banting Lecture 1988. Role of Insulin Resistance in Human Disease, Diabetes, 1988, vol. 37, pp. 1595–1607.PubMedCrossRefGoogle Scholar
  2. 2.
    Isomaa, B., Almgren, P., Tuomi, T., et al., Cardiovascular Morbidity and Mortality Associated with the Metabolic syndrome, Diabet. Care, 2001, vol. 24, pp. 683–689.CrossRefGoogle Scholar
  3. 3.
    Desvergne, B. and Wahli, W., Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism, Endocr. Res., 1999, vol. 20, pp. 649–688.CrossRefGoogle Scholar
  4. 4.
    Gurnell, M., David, D., Savage, V., Krishna, K., et al., The metabolic Syndrome: Peroxisome Receptor γ and its Therapeutic Modulation, Clin. Endocr. Metab., 2003, vol. 88, no. 6, pp. 2412–2421.CrossRefGoogle Scholar
  5. 5.
    Kaydashev, I.P., Rasin, M.S., and Savchenko, L.G., Type I Angiotensin II Receptor Polymorphism in Patients with Essential Hypertension in the Ukrainian Population, Tsitol. Genet., 2005, vol. 39, no. 5, pp. 51–55 [Cytol. Genet. (Engl. Transl.), 2005, vol. 39, no. 5].Google Scholar
  6. 6.
    Lenfant, C., Definition of the Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute, Amer. Assoc. Conf. on Scientific Issues Related to Definition, Circulation, 2004, vol. 109, pp. 433–438.PubMedCrossRefGoogle Scholar
  7. 7.
    Malecki, T.M., Fray, J., and Clupea, T., The Pro12Alapolymorphism of PPARγ2 Gene and Susceptibility to Type 2 Diabetes Mellitus in a Polish Population, Diabetes Res. Clin. Practice, 2003, vol. 62, no. 2, pp. 105–111.CrossRefGoogle Scholar
  8. 8.
    Stumvoll, M. and Haring, H., Peroxisome Proliferator-activated Receptor—[gamma] Pro12Ala Polymorphism-Perspectives in Diabetes, Diabetes, 2002, vol. 8, pp. 43–54.Google Scholar
  9. 9.
    Mori, H., Ikegami, H., Kawaguchi, Y., and Seine, S., PRo12 Ala Substitution in PPAR Gamma: is Associated with Resistance to Development of Diabetes in the General Population: Possible Involvement in Impairment of Insulin Secretion in Individuals with Type 2 Diabetes, Diabetes, 2001, vol. 50, pp. 891–894.PubMedCrossRefGoogle Scholar
  10. 10.
    Pinterova, D., Cerna, M., Kolostova, K., et al., The Frequency of Alleles of the Pro12Ala Polymorphism in PPARgamma2 is Different Between Healthy Controls and Patients with Type 2 Diabetes, Folia Biol (Prague), 2004, vol. 50, no. 5, pp. 153–156.Google Scholar
  11. 11.
    Alshuler, D., Hirschhold, J.N., Klannemark, M., et al., The Common PPARgamma Pro12Ala Polymorphism is Associated with Decreased Risk of Type 2 Diabetes, Nat. Genet., 2000, vol. 26, pp. 76–80.CrossRefGoogle Scholar
  12. 12.
    Desvergne, B., Michalik, L., and Wahli, W., Be Fit or Be Sick: Peroxisome Proliferator-activated Receptors are Down the Road, Mol. Endocr., 2004, vol. 18, no. 6, pp. 1321–1332.CrossRefGoogle Scholar
  13. 13.
    Walczak, R. and Tontonoz, P., PPARadigms and PPARadoxes: Expanding Roles for PPARγ in the Control of Lipid Metabolism, J. Lipid Res., 2002, vol. 43, pp. 177–186.PubMedGoogle Scholar

Copyright information

© Allerton Press, Inc. 2007

Authors and Affiliations

  • I. P. Kaydashev
    • 1
  • A. M. Rasin
    • 1
  • O. A. Shlykova
    • 1
  • I. M. Gorbas’
    • 1
  • I. P. Smirnova
    • 1
  • A. V. Petrushov
    • 1
  • M. S. Rasin
    • 1
  1. 1.Ukrainian Medical Stomatological AcademyPoltavaUkraine

Personalised recommendations